Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 532 entries
Sorted by: Best Match Show Resources per page
Pharmacists' knowledge of the safety of antibiotics for systemic use.

The International journal of risk & safety in medicine

Yakimova Y.
PMID: 26639686
Int J Risk Saf Med. 2015;27:S11-2. doi: 10.3233/JRS-150670.

BACKGROUND: Patients decide to take antibiotics themselves in 21% of cases of acute respiratory viral infections, influenza and acute respiratory infections [1]. The main factor of drug purchase at a pharmacy is pharmacist's recommendation. In 14% of cases of...

Cite
Yakimova Y. Pharmacists' knowledge of the safety of antibiotics for systemic use. Int J Risk Saf Med. 2015;27:S11-2doi: 10.3233/JRS-150670.
Yakimova, Y. (2015). Pharmacists' knowledge of the safety of antibiotics for systemic use. The International journal of risk & safety in medicine, 27S11-2. https://doi.org/10.3233/JRS-150670
Yakimova, Y. "Pharmacists' knowledge of the safety of antibiotics for systemic use." The International journal of risk & safety in medicine vol. 27 (2015): S11-2. doi: https://doi.org/10.3233/JRS-150670
Yakimova Y. Pharmacists' knowledge of the safety of antibiotics for systemic use. Int J Risk Saf Med. 2015;27:S11-2. doi: 10.3233/JRS-150670. PMID: 26639686.
Copy Download .nbib Format: NLM
Prenatal Exposure to Teratogenic Medications in the Era of Risk Evaluation and Mitigation Strategies (REMS).

American journal of obstetrics and gynecology

Sarayani A, Albogami Y, Thai TN, Smolinski NE, Patel P, Wang Y, Nduaguba S, Rasmussen SA, Winterstein AG.
PMID: 35032444
Am J Obstet Gynecol. 2022 Jan 12; doi: 10.1016/j.ajog.2022.01.004. Epub 2022 Jan 12.

BACKGROUND: Prevention of prenatal exposures to teratogenic drugs is a significant clinical and public health concern. With the enactment of the FDA Amendment Act in 2007, the Food and Drug Administration has begun to require manufacturers to implement Risk...

Cite
Sarayani A, Albogami Y, Thai TN, et al. Prenatal Exposure to Teratogenic Medications in the Era of Risk Evaluation and Mitigation Strategies (REMS). Am J Obstet Gynecol. 2022;doi: 10.1016/j.ajog.2022.01.004.
Sarayani, A., Albogami, Y., Thai, T. N., Smolinski, N. E., Patel, P., Wang, Y., Nduaguba, S., Rasmussen, S. A., & Winterstein, A. G. (2022). Prenatal Exposure to Teratogenic Medications in the Era of Risk Evaluation and Mitigation Strategies (REMS). American journal of obstetrics and gynecology, . https://doi.org/10.1016/j.ajog.2022.01.004
Sarayani, Amir, et al. "Prenatal Exposure to Teratogenic Medications in the Era of Risk Evaluation and Mitigation Strategies (REMS)." American journal of obstetrics and gynecology vol. (2022). doi: https://doi.org/10.1016/j.ajog.2022.01.004
Sarayani A, Albogami Y, Thai TN, Smolinski NE, Patel P, Wang Y, Nduaguba S, Rasmussen SA, Winterstein AG. Prenatal Exposure to Teratogenic Medications in the Era of Risk Evaluation and Mitigation Strategies (REMS). Am J Obstet Gynecol. 2022 Jan 12; doi: 10.1016/j.ajog.2022.01.004. Epub 2022 Jan 12. PMID: 35032444.
Copy Download .nbib Format: NLM
Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends.

JAMA internal medicine

Tran PT, Antonelli PJ, Hincapie-Castillo JM, Winterstein AG.
PMID: 33871571
JAMA Intern Med. 2021 Jun 01;181(6):808-816. doi: 10.1001/jamainternmed.2021.1154.

IMPORTANCE: In May 2016, due to concerns of the risks outweighing the benefits, the US Food and Drug Administration (FDA) removed systemic quinolones' indications for acute, uncomplicated urinary tract infection (uUTI), acute sinusitis (AS), and acute exacerbation of chronic...

Cite
Tran PT, Antonelli PJ, Hincapie-Castillo JM, et al. Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends. JAMA Intern Med. 2021;181(6):808-816doi: 10.1001/jamainternmed.2021.1154.
Tran, P. T., Antonelli, P. J., Hincapie-Castillo, J. M., & Winterstein, A. G. (2021). Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends. JAMA internal medicine, 181(6), 808-816. https://doi.org/10.1001/jamainternmed.2021.1154
Tran, Phuong T, et al. "Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends." JAMA internal medicine vol. 181,6 (2021): 808-816. doi: https://doi.org/10.1001/jamainternmed.2021.1154
Tran PT, Antonelli PJ, Hincapie-Castillo JM, Winterstein AG. Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends. JAMA Intern Med. 2021 Jun 01;181(6):808-816. doi: 10.1001/jamainternmed.2021.1154. PMID: 33871571; PMCID: PMC8056313.
Copy Download .nbib Format: NLM
Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends.

JAMA internal medicine

Tran PT, Antonelli PJ, Hincapie-Castillo JM, Winterstein AG.
PMID: 33871571
JAMA Intern Med. 2021 Jun 01;181(6):808-816. doi: 10.1001/jamainternmed.2021.1154.

IMPORTANCE: In May 2016, due to concerns of the risks outweighing the benefits, the US Food and Drug Administration (FDA) removed systemic quinolones' indications for acute, uncomplicated urinary tract infection (uUTI), acute sinusitis (AS), and acute exacerbation of chronic...

Cite
Tran PT, Antonelli PJ, Hincapie-Castillo JM, et al. Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends. JAMA Intern Med. 2021;181(6):808-816doi: 10.1001/jamainternmed.2021.1154.
Tran, P. T., Antonelli, P. J., Hincapie-Castillo, J. M., & Winterstein, A. G. (2021). Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends. JAMA internal medicine, 181(6), 808-816. https://doi.org/10.1001/jamainternmed.2021.1154
Tran, Phuong T, et al. "Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends." JAMA internal medicine vol. 181,6 (2021): 808-816. doi: https://doi.org/10.1001/jamainternmed.2021.1154
Tran PT, Antonelli PJ, Hincapie-Castillo JM, Winterstein AG. Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends. JAMA Intern Med. 2021 Jun 01;181(6):808-816. doi: 10.1001/jamainternmed.2021.1154. PMID: 33871571; PMCID: PMC8056313.
Copy Download .nbib Format: NLM
Periodontal Therapy: Prospects for the Future.

Journal of periodontology

Page RC.
PMID: 29539755
J Periodontol. 1993 Aug;64:744-753. doi: 10.1902/jop.1993.64.8s.744.

Prior to the 1950s, periodontitis was treated mostly by tooth exfoliation or extraction, and that is still the predominant treatment for most of the world's populations today. Debridement of the root surface by scaling and root planing came into...

Cite
Page RC. Periodontal Therapy: Prospects for the Future. J Periodontol. 1993;64:744-753doi: 10.1902/jop.1993.64.8s.744.
Page, R. C. (1993). Periodontal Therapy: Prospects for the Future. Journal of periodontology, 64744-753. https://doi.org/10.1902/jop.1993.64.8s.744
Page, Roy C. "Periodontal Therapy: Prospects for the Future." Journal of periodontology vol. 64 (1993): 744-753. doi: https://doi.org/10.1902/jop.1993.64.8s.744
Page RC. Periodontal Therapy: Prospects for the Future. J Periodontol. 1993 Aug;64:744-753. doi: 10.1902/jop.1993.64.8s.744. PMID: 29539755.
Copy Download .nbib Format: NLM
Issues in the diagnosis and treatment of lyme disease.

The open neurology journal

Donta ST.
PMID: 23248715
Open Neurol J. 2012;6:140-5. doi: 10.2174/1874205X01206010140. Epub 2012 Nov 30.

Since the identification of the causative organism more than 30 years ago, there remain questions about the di-agnosis and treatment of Lyme Disease. In this article, what is known about the disease will be reviewed, and approaches to the...

Cite
Donta ST. Issues in the diagnosis and treatment of lyme disease. Open Neurol J. 2012;6:140-5doi: 10.2174/1874205X01206010140.
Donta, S. T. (2012). Issues in the diagnosis and treatment of lyme disease. The open neurology journal, 6140-5. https://doi.org/10.2174/1874205X01206010140
Donta, Sam T. "Issues in the diagnosis and treatment of lyme disease." The open neurology journal vol. 6 (2012): 140-5. doi: https://doi.org/10.2174/1874205X01206010140
Donta ST. Issues in the diagnosis and treatment of lyme disease. Open Neurol J. 2012;6:140-5. doi: 10.2174/1874205X01206010140. Epub 2012 Nov 30. PMID: 23248715; PMCID: PMC3520031.
Copy Download .nbib Format: NLM
In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes.

The Journal of clinical and aesthetic dermatology

Leyden JJ, Preston N, Osborn C, Gottschalk RW.
PMID: 21607190
J Clin Aesthet Dermatol. 2011 May;4(5):22-6.

BACKGROUND: A gel combination treatment containing a retinoid (adapalene 0.1%) and an antimicrobial (benzoyl peroxide 2.5%) has been shown to be an effective treatment for acne vulgaris, addressing three of the four pathogenic factors (hyperkeratinization, Propionibacterium acnes proliferation, inflammation)...

Cite
Leyden JJ, Preston N, Osborn C, et al. In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes. J Clin Aesthet Dermatol. 2011;4(5):22-6
Leyden, J. J., Preston, N., Osborn, C., & Gottschalk, R. W. (2011). In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes. The Journal of clinical and aesthetic dermatology, 4(5), 22-6.
Leyden, James J, et al. "In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes." The Journal of clinical and aesthetic dermatology vol. 4,5 (2011): 22-6.
Leyden JJ, Preston N, Osborn C, Gottschalk RW. In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes. J Clin Aesthet Dermatol. 2011 May;4(5):22-6. PMID: 21607190; PMCID: PMC3100113.
Copy Download .nbib Format: NLM
Antimicrobial usage in cattle and poultry production in Dar es Salaam, Tanzania: pattern and quantity.

BMC veterinary research

Azabo R, Mshana S, Matee M, Kimera SI.
PMID: 34980101
BMC Vet Res. 2022 Jan 03;18(1):7. doi: 10.1186/s12917-021-03056-9.

BACKGROUND: Antimicrobials are extensively used in cattle and poultry production in Tanzania. However, there is dearth of information on its quantitative use. A questionnaire-based cross-sectional study was conducted from August to September 2019 in randomly selected poultry and small-scale...

Cite
Azabo R, Mshana S, Matee M, et al. Antimicrobial usage in cattle and poultry production in Dar es Salaam, Tanzania: pattern and quantity. BMC Vet Res. 2022;18(1):7doi: 10.1186/s12917-021-03056-9.
Azabo, R., Mshana, S., Matee, M., & Kimera, S. I. (2022). Antimicrobial usage in cattle and poultry production in Dar es Salaam, Tanzania: pattern and quantity. BMC veterinary research, 18(1), 7. https://doi.org/10.1186/s12917-021-03056-9
Azabo, Rogers, et al. "Antimicrobial usage in cattle and poultry production in Dar es Salaam, Tanzania: pattern and quantity." BMC veterinary research vol. 18,1 (2022): 7. doi: https://doi.org/10.1186/s12917-021-03056-9
Azabo R, Mshana S, Matee M, Kimera SI. Antimicrobial usage in cattle and poultry production in Dar es Salaam, Tanzania: pattern and quantity. BMC Vet Res. 2022 Jan 03;18(1):7. doi: 10.1186/s12917-021-03056-9. PMID: 34980101; PMCID: PMC8722348.
Copy Download .nbib Format: NLM
Prescribing antibiotics: the use of diagnostic tests in general practice. A register-based study.

Scandinavian journal of primary health care

Sydenham RV, Justesen US, Hansen MP, Pedersen LB, Aabenhus RM, Wehberg S, Jarbøl DE.
PMID: 34845954
Scand J Prim Health Care. 2021 Dec;39(4):466-475. doi: 10.1080/02813432.2021.2004721. Epub 2021 Nov 30.

OBJECTIVE: To assess (i) the pattern of antibiotic prescribing in Danish general practice, (ii) the use of diagnostic tests [point-of-care (POC) and tests analysed at the hospital laboratory (laboratory tests)], and (iii) the frequency of diagnostic testing in relation...

Cite
Sydenham RV, Justesen US, Hansen MP, et al. Prescribing antibiotics: the use of diagnostic tests in general practice. A register-based study. Scand J Prim Health Care. 2021;39(4):466-475doi: 10.1080/02813432.2021.2004721.
Sydenham, R. V., Justesen, U. S., Hansen, M. P., Pedersen, L. B., Aabenhus, R. M., Wehberg, S., & Jarbøl, D. E. (2021). Prescribing antibiotics: the use of diagnostic tests in general practice. A register-based study. Scandinavian journal of primary health care, 39(4), 466-475. https://doi.org/10.1080/02813432.2021.2004721
Sydenham, Rikke Vognbjerg, et al. "Prescribing antibiotics: the use of diagnostic tests in general practice. A register-based study." Scandinavian journal of primary health care vol. 39,4 (2021): 466-475. doi: https://doi.org/10.1080/02813432.2021.2004721
Sydenham RV, Justesen US, Hansen MP, Pedersen LB, Aabenhus RM, Wehberg S, Jarbøl DE. Prescribing antibiotics: the use of diagnostic tests in general practice. A register-based study. Scand J Prim Health Care. 2021 Dec;39(4):466-475. doi: 10.1080/02813432.2021.2004721. Epub 2021 Nov 30. PMID: 34845954.
Copy Download .nbib Format: NLM
Antimicrobial usage in cattle and poultry production in Dar es Salaam, Tanzania: pattern and quantity.

BMC veterinary research

Azabo R, Mshana S, Matee M, Kimera SI.
PMID: 34980101
BMC Vet Res. 2022 Jan 03;18(1):7. doi: 10.1186/s12917-021-03056-9.

BACKGROUND: Antimicrobials are extensively used in cattle and poultry production in Tanzania. However, there is dearth of information on its quantitative use. A questionnaire-based cross-sectional study was conducted from August to September 2019 in randomly selected poultry and small-scale...

Cite
Azabo R, Mshana S, Matee M, et al. Antimicrobial usage in cattle and poultry production in Dar es Salaam, Tanzania: pattern and quantity. BMC Vet Res. 2022;18(1):7doi: 10.1186/s12917-021-03056-9.
Azabo, R., Mshana, S., Matee, M., & Kimera, S. I. (2022). Antimicrobial usage in cattle and poultry production in Dar es Salaam, Tanzania: pattern and quantity. BMC veterinary research, 18(1), 7. https://doi.org/10.1186/s12917-021-03056-9
Azabo, Rogers, et al. "Antimicrobial usage in cattle and poultry production in Dar es Salaam, Tanzania: pattern and quantity." BMC veterinary research vol. 18,1 (2022): 7. doi: https://doi.org/10.1186/s12917-021-03056-9
Azabo R, Mshana S, Matee M, Kimera SI. Antimicrobial usage in cattle and poultry production in Dar es Salaam, Tanzania: pattern and quantity. BMC Vet Res. 2022 Jan 03;18(1):7. doi: 10.1186/s12917-021-03056-9. PMID: 34980101.
Copy Download .nbib Format: NLM
Prescribing antibiotics: the use of diagnostic tests in general practice. A register-based study.

Scandinavian journal of primary health care

Sydenham RV, Justesen US, Hansen MP, Pedersen LB, Aabenhus RM, Wehberg S, Jarbøl DE.
PMID: 34845954
Scand J Prim Health Care. 2021 Dec;39(4):466-475. doi: 10.1080/02813432.2021.2004721. Epub 2021 Nov 30.

OBJECTIVE: To assess (i) the pattern of antibiotic prescribing in Danish general practice, (ii) the use of diagnostic tests [point-of-care (POC) and tests analysed at the hospital laboratory (laboratory tests)], and (iii) the frequency of diagnostic testing in relation...

Cite
Sydenham RV, Justesen US, Hansen MP, et al. Prescribing antibiotics: the use of diagnostic tests in general practice. A register-based study. Scand J Prim Health Care. 2021;39(4):466-475doi: 10.1080/02813432.2021.2004721.
Sydenham, R. V., Justesen, U. S., Hansen, M. P., Pedersen, L. B., Aabenhus, R. M., Wehberg, S., & Jarbøl, D. E. (2021). Prescribing antibiotics: the use of diagnostic tests in general practice. A register-based study. Scandinavian journal of primary health care, 39(4), 466-475. https://doi.org/10.1080/02813432.2021.2004721
Sydenham, Rikke Vognbjerg, et al. "Prescribing antibiotics: the use of diagnostic tests in general practice. A register-based study." Scandinavian journal of primary health care vol. 39,4 (2021): 466-475. doi: https://doi.org/10.1080/02813432.2021.2004721
Sydenham RV, Justesen US, Hansen MP, Pedersen LB, Aabenhus RM, Wehberg S, Jarbøl DE. Prescribing antibiotics: the use of diagnostic tests in general practice. A register-based study. Scand J Prim Health Care. 2021 Dec;39(4):466-475. doi: 10.1080/02813432.2021.2004721. Epub 2021 Nov 30. PMID: 34845954.
Copy Download .nbib Format: NLM
Revealing antimicrobial resistance profile of the novel probiotic candidate Faecalibacterium prausnitzii DSM 17677.

International journal of food microbiology

Machado D, Barbosa JC, Domingos M, Almeida D, Andrade JC, Freitas AC, Gomes AM.
PMID: 34953344
Int J Food Microbiol. 2021 Dec 13;363:109501. doi: 10.1016/j.ijfoodmicro.2021.109501. Epub 2021 Dec 13.

Faecalibacterium prausnitzii, a resident anaerobic bacterium commonly found in healthy gut microbiota, has been proposed as a next generation probiotic with high potential for application in food matrices and pharmaceutical formulations. Despite its recognized health benefits, detailed information regarding...

Cite
Machado D, Barbosa JC, Domingos M, et al. Revealing antimicrobial resistance profile of the novel probiotic candidate Faecalibacterium prausnitzii DSM 17677. Int J Food Microbiol. 2021;363:109501doi: 10.1016/j.ijfoodmicro.2021.109501.
Machado, D., Barbosa, J. C., Domingos, M., Almeida, D., Andrade, J. C., Freitas, A. C., & Gomes, A. M. (2021). Revealing antimicrobial resistance profile of the novel probiotic candidate Faecalibacterium prausnitzii DSM 17677. International journal of food microbiology, 363109501. https://doi.org/10.1016/j.ijfoodmicro.2021.109501
Machado, Daniela, et al. "Revealing antimicrobial resistance profile of the novel probiotic candidate Faecalibacterium prausnitzii DSM 17677." International journal of food microbiology vol. 363 (2021): 109501. doi: https://doi.org/10.1016/j.ijfoodmicro.2021.109501
Machado D, Barbosa JC, Domingos M, Almeida D, Andrade JC, Freitas AC, Gomes AM. Revealing antimicrobial resistance profile of the novel probiotic candidate Faecalibacterium prausnitzii DSM 17677. Int J Food Microbiol. 2021 Dec 13;363:109501. doi: 10.1016/j.ijfoodmicro.2021.109501. Epub 2021 Dec 13. PMID: 34953344.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 532 entries